What is the significance of an abnormally elevated Plasma Aldosterone Concentration (PAC) or Aldosterone-to-Renin Ratio (ARR) in the evaluation of primary aldosteronism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

An abnormally elevated plasma aldosterone concentration (PAC) is typically considered to be >15 ng/dL (>416 pmol/L), while an elevated aldosterone-to-renin ratio (ARR) is generally defined as >30 when plasma aldosterone concentration is reported in nanograms per deciliter (ng/dL) and plasma renin activity in nanograms per milliliter per hour (ng/mL/h). The ARR is the preferred initial screening test for primary aldosteronism, as it accounts for both aldosterone levels and renin activity, as stated in the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults 1. An elevated ARR suggests inappropriate aldosterone production relative to the renin-angiotensin system status.

Key Considerations

  • The plasma aldosterone concentration should be at least 10 ng/dL to interpret the test as positive, as noted in the guideline 1.
  • Patients should have unrestricted salt intake, serum potassium in the normal range, and mineralocorticoid receptor antagonists (e.g., spironolactone or eplerenone) withdrawn for at least 4 weeks before testing 1.
  • Antihypertensives like beta-blockers, ACE inhibitors, ARBs, and diuretics should ideally be discontinued for 2-4 weeks before testing.
  • Hypokalemia should be corrected, and patients should maintain a normal sodium diet.
  • Morning blood sampling is preferred with the patient in a seated position for at least 5-15 minutes.

Additional Testing

A positive screening test requires confirmation with additional tests such as salt loading, captopril challenge, or fludrocortisone suppression test before proceeding to adrenal imaging and adrenal vein sampling, as recommended in the guideline 1. If the diagnosis of primary aldosteronism is confirmed, the patient is referred for an adrenal venous sampling procedure to determine whether the increased aldosterone production is unilateral or bilateral in origin.

Treatment

If unilateral aldosterone production is documented on adrenal venous sampling, the patient is referred for unilateral laparoscopic adrenalectomy, which improves BP in virtually 100% of patients and results in a complete cure of hypertension in about 50% 1. If the patient has bilaterally increased aldosterone secretion on adrenal venous sampling or has a unilateral source of excess aldosterone production but cannot undergo surgery, the patient is treated with spironolactone or eplerenone as agent of choice 1.

From the Research

Definition of Abnormally Elevated PAC or ARR

An abnormally elevated plasma aldosterone concentration (PAC) or aldosterone-renin ratio (ARR) is a key indicator of primary aldosteronism (PA) 2, 3, 4, 5, 6.

Criteria for Elevated PAC or ARR

The criteria for an elevated PAC or ARR vary, but a commonly used threshold is an ARR greater than 30 3.

Diagnostic Process

The diagnostic process for primary aldosteronism typically involves:

  • Initial case detection using the plasma aldosterone concentration to plasma renin activity ratio (PAC/PRA) or ARR 4, 6
  • Confirmatory testing, such as the captopril challenge, oral or intravenous salt loading, or fludrocortisone suppression, to confirm autonomous aldosterone production 3, 4, 6
  • Adrenal computed tomography and adrenal vein sampling to differentiate unilateral from bilateral adrenal production of aldosterone 3, 5, 6

Treatment Options

Treatment options for primary aldosteronism depend on the subtype and may include:

  • Unilateral adrenalectomy for aldosterone-producing adenoma or unilateral hyperplasia 3, 5, 6
  • Pharmacological treatment with mineralocorticoid receptor antagonists, such as spironolactone or eplerenone, for bilateral hyperplasia or glucocorticoid-remediable aldosteronism 3, 5, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Primary Aldosteronism.

American family physician, 2023

Research

Detecting and treating primary aldosteronism: primary aldosteronism.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2007

Research

Primary Aldosteronism: Present and Future.

Vitamins and hormones, 2019

Research

Primary aldosteronism: diagnostic and treatment strategies.

Nature clinical practice. Nephrology, 2006

Related Questions

Should renin and aldosterone levels be measured in serum when evaluating primary hyperaldosteronism (Hyperaldosteronism)?
What labs are used to diagnose primary hyperaldosteronism (Primary Aldosteronism)?
What is the prevalence of primary hyperaldosteronism (Conn's syndrome)?
What is the best medical therapy for confirmed primary aldosteronism (PA) due to bilateral hyperplasia?
What are normal aldosterone levels in adults?
What is the significance of 50,000-100,000 Colony-Forming Units per Milliliter (CFU/mL) of coagulase-negative Staphylococcus (Staphylococcus species other than Staphylococcus aureus)?
What is the optimal management plan for a 70-year-old male with End-Stage Renal Disease (ESRD) on Hemodialysis (HD), resistant Hypertension (HTN), Heart Failure with preserved Ejection Fraction (HFpEF), Coronary Artery Disease (CAD), Gastroesophageal Reflux Disease (GERD), and Type 2 Diabetes Mellitus (T2DM), who presents with improved symptoms after hospital discharge for hypertensive urgency and hematemesis, and is currently taking carvedilol (Coreg) (carvedilol), lisinopril (Zestril) (lisinopril), amlodipine (Norvasc) (amlodipine), doxazosin (Cardura) (doxazosin), hydralazine (Apresoline) (hydralazine), and furosemide (Lasix) (furosemide)?
What is the optimal timing and duration for administering Pre-Exposure Prophylaxis (PrEP) in the event of possible Human Immunodeficiency Virus (HIV) exposure?
What are Brain-Computer Interfaces (BCIs)?
Can a patient undergo dental cleaning after hip arthroscopy?
What are the effects of chemical ocular (eye) damage?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.